Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasopharyngeal Cancinoma (NPC)”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableStudy completedNCT05292027
What this trial is testing

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 84
Early research (Phase 1)Looking for participantsNCT07625423
What this trial is testing

Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors

Who this might be right for
Head & Neck CancerNasopharyngeal Cancinoma (NPC)
West China Hospital 9
Large-scale testing (Phase 3)Looking for participantsNCT06749899
What this trial is testing

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-Sen University Cancer Center 580
Not applicableLooking for participantsNCT07376603
What this trial is testing

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Intensity-modulated RadiotherapyStage IB
Qiaojuan Guo 169
Large-scale testing (Phase 3)Active Not RecruitingNCT06664983
What this trial is testing

TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 84
Large-scale testing (Phase 3)Looking for participantsNCT07154069
What this trial is testing

Adaptive Immunotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 802
Large-scale testing (Phase 3)Looking for participantsNCT07796789
What this trial is testing

Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 204
Testing effectiveness (Phase 2)Looking for participantsNCT07362979
What this trial is testing

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 243
Testing effectiveness (Phase 2)Looking for participantsNCT07528183
What this trial is testing

Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Looking for participantsNCT06676722
What this trial is testing

SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy

Who this might be right for
Nasopharyngeal Cancinoma (NPC)SBRTImmunotherapy
The First Affiliated Hospital of Xiamen University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07067268
What this trial is testing

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Fudan University 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381699
What this trial is testing

MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
West China Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07325539
What this trial is testing

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharangeal Cancer
Sun Yat-sen University 55
Not applicableActive Not RecruitingNCT07042711
What this trial is testing

Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Universitas Indonesia 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138989
What this trial is testing

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 10
Not applicableLooking for participantsNCT07013461
What this trial is testing

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
The University of Hong Kong-Shenzhen Hospital 5,000
Not applicableActive Not RecruitingNCT07248696
What this trial is testing

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Chongqing University Cancer Hospital 32
Large-scale testing (Phase 3)Not Yet RecruitingNCT07524413
What this trial is testing

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 514
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06605131
What this trial is testing

GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 72
Testing effectiveness (Phase 2)Looking for participantsNCT06788002
What this trial is testing

LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Hunan Cancer Hospital 26
Next Page